Body Plethysmography--its Principles and Clinical Use
Overview
Authors
Affiliations
Body plethysmography allows to assess functional residual capacity (FRC(pleth)) and specific airway resistance (sRaw) as primary measures. In combination with deep expirations and inspirations, total lung capacity (TLC) and residual volume (RV) can be determined. Airway resistance (Raw) is calculated as the ratio of sRaw to FRC(pleth). Raw is a measure of airway obstruction and indicates the alveolar pressure needed to establish a flow rate of 1 L s(-1). In contrast, sRaw can be interpreted as the work to be performed by volume displacement to establish this flow rate. These measures represent different functional aspects and should both be considered. The measurement relies on the fact that generation of airflow needs generation of pressure. Pressure generation means that a mass of air is compressed or decompressed relative to its equilibrium volume. This difference is called "shift volume". As the body box is sealed and has rigid walls, its free volume experiences the same, mirror image-like shift volume as the lung. This shift volume can be measured via the variation of box pressure. The relationship between shift volume and alveolar pressure is assessed in a shutter maneuver, by identifying mouth and alveolar pressure under zero-flow conditions. These variables are combined to obtain FRC(pleth), sRaw and Raw. This presentation aims at providing the reader with a thorough and precise but non-technical understanding of the working principle of body plethysmography. It also aims at showing that this method yields significant additional information compared to spirometry and even bears a potential for further development.
pulmonary infection and associated respiratory function in cystic fibrosis-like βENaC mice.
Pearce C, Shaw T, Podell B, Jackson M, Henao-Tamayo M, Obregon-Henao A Front Tuberc. 2025; 2.
PMID: 39950136 PMC: 11822858. DOI: 10.3389/ftubr.2024.1473341.
A Novel Medical Device for Airway Clearance.
Helper N, Ashkenazi M, Sokol G, Dagan A, Efrati O J Clin Med. 2025; 14(3).
PMID: 39941578 PMC: 11818876. DOI: 10.3390/jcm14030907.
Karamarkovic Lazarusic N, Popovic-Grle S, Tolic E, Stajduhar A, Bozinovic R, Pavlisa G J Clin Med. 2025; 14(1.
PMID: 39797163 PMC: 11721349. DOI: 10.3390/jcm14010074.
Biciusca V, Rosu A, Stan S, Cioboata R, Biciusca T, Balteanu M Diagnostics (Basel). 2024; 14(23).
PMID: 39682582 PMC: 11639850. DOI: 10.3390/diagnostics14232674.
Alter P, Kahnert K, Trudzinski F, Bals R, Watz H, Speicher T Int J Chron Obstruct Pulmon Dis. 2024; 19():2629-2638.
PMID: 39655060 PMC: 11626970. DOI: 10.2147/COPD.S475112.